Rating History for Erasca Inc (ERAS) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for ERAS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/13/2026 Kevin Strang New Coverage Early-Stage Biotech
(N/A)		 N/A
(N/A)		 18.53
(19.17)		 3.45% Details